Caris Biorepository Research Protocol
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCaris Science, Inc.
About this trial
The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients.
The Caris Biorepository is a repository of prospectively collected biological specimens and associated clinical and demographic data gathered from multiple sources to be stored, used and shared for research. Caris Life Sciences will maintain the data and specimens and will control access to and use of the information and specimens by multiple individuals for multiple purposes which may evolve over time.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
18 years of age or older
Capacity to provide informed consent
Disqualifiers
Due to the complexity of state and federal requirements governing the participation of prisoners in research, prisoners-patients will not be approached for participation in the Caris Biorepository.
Minor subjects will not be included in the Caris Biorepository, as it is possible biospecimens and data may be stored beyond the time limitations of assent and it may be impracticable to re-consent these subjects once they become adults.
Individuals who lack the capacity to give informed consent
Trial population
Healthy volunteers as well as those with a known disease state or condition
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
100,000 Participants
are grouped into 5 trial groupsGroup A: Normal
Group B: Newly Diagnosed Pan-Cancer Collection
Group C: Early Detection Collection
Group D: Advanced Stage Cancer Collection
Group E: Minimal Residual Disease Collection
Trial outcomes
Primary outcomes
1
Develop biorepository that ensures molecular integrity and clinical relevance of quality human biospecimens and associated clinical data.
Retention of biospecimen samples with DNA
Time frame
35 years2
Implement release of specimens from biorepository for testing
Research for the purposes of cancer laboratory diagnostic tests.
Time frame
35 yearsSecondary outcomes
1
Laboratory testing
DNA and RNA microarray
Time frame
35 years2
Laboratory testing
Immunohistochemistry
Time frame
35 years3
Laboratory testing
Gene and protein expression, proteomics and matabolomics
Time frame
35 years4
Laboratory testing
Mutation analysis
Time frame
35 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov